Back to search

Article

MYL2 is a potential diagnostic, prognostic, and immune biomarker for HNSC

2022-10-12

Abstract excerpt

<title>Abstract</title> <p>The significance of MYL2 as a possible HNSC treatment gene is unknown, the purpose of this study was to determine the exact involvement of MYL2 in HNSC.The Tumor Immune Estimate Resource (TIMER), UALCAN, The Cancer Genome Atlas (TCGA), and Gene Expression Omnibus (GEO) databases were used to assess MYL2 mRNA and protein expression levels in HNSC. Experimental tests, including immunohist...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
354b3368-3818-5f7f-af80-044044994c55
DOI
10.21203/rs.3.rs-2142569/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MYL2 is a potential diagnostic, prognostic, and immune biomarker for HNSCDOI 10.21203/rs.3.rs-2142569/v1
Select a neighboring publication to make it the new centre.